108 related articles for article (PubMed ID: 15277728)
1. [Aldosterone and renal injury].
Nishiyama A; Abe Y
Nihon Yakurigaku Zasshi; 2004 Aug; 124(2):101-9. PubMed ID: 15277728
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade.
Nishiyama A; Abe Y
J Pharmacol Sci; 2006 Jan; 100(1):9-16. PubMed ID: 16397374
[TBL] [Abstract][Full Text] [Related]
3. Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats.
Nishiyama A; Yao L; Nagai Y; Miyata K; Yoshizumi M; Kagami S; Kondo S; Kiyomoto H; Shokoji T; Kimura S; Kohno M; Abe Y
Hypertension; 2004 Apr; 43(4):841-8. PubMed ID: 14769808
[TBL] [Abstract][Full Text] [Related]
4. Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury.
Kiyomoto H; Rafiq K; Mostofa M; Nishiyama A
J Pharmacol Sci; 2008 Dec; 108(4):399-405. PubMed ID: 19057124
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease.
Brem AS; Gong R
Clin Sci (Lond); 2015 May; 128(9):527-35. PubMed ID: 25671776
[TBL] [Abstract][Full Text] [Related]
6. [Role of aldosterone in oxidative stress and renal injury].
Nishiyama A; Kusaka T; Kitajima H
Yakugaku Zasshi; 2007 Sep; 127(9):1331-7. PubMed ID: 17827915
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells.
Miyata K; Rahman M; Shokoji T; Nagai Y; Zhang GX; Sun GP; Kimura S; Yukimura T; Kiyomoto H; Kohno M; Abe Y; Nishiyama A
J Am Soc Nephrol; 2005 Oct; 16(10):2906-12. PubMed ID: 16135774
[TBL] [Abstract][Full Text] [Related]
8. Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability.
Nishiyama A; Yao L; Fan Y; Kyaw M; Kataoka N; Hashimoto K; Nagai Y; Nakamura E; Yoshizumi M; Shokoji T; Kimura S; Kiyomoto H; Tsujioka K; Kohno M; Tamaki T; Kajiya F; Abe Y
Hypertension; 2005 Apr; 45(4):710-6. PubMed ID: 15699469
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiological roles of aldosterone and mineralocorticoid receptor in the kidney.
Rafiq K; Hitomi H; Nakano D; Nishiyama A
J Pharmacol Sci; 2011; 115(1):1-7. PubMed ID: 21186336
[TBL] [Abstract][Full Text] [Related]
10. Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress.
Nagase M; Matsui H; Shibata S; Gotoda T; Fujita T
Hypertension; 2007 Nov; 50(5):877-83. PubMed ID: 17875821
[TBL] [Abstract][Full Text] [Related]
11. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.
Shibata S; Nagase M; Yoshida S; Kawachi H; Fujita T
Hypertension; 2007 Feb; 49(2):355-64. PubMed ID: 17200434
[TBL] [Abstract][Full Text] [Related]
12. The renal effects of mineralocorticoid receptor antagonists.
Bianchi S; Batini V; Bigazzi R
Int J Cardiol; 2015 Dec; 200():20-4. PubMed ID: 26049733
[TBL] [Abstract][Full Text] [Related]
13. Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation.
Otani H; Otsuka F; Inagaki K; Takeda M; Miyoshi T; Suzuki J; Mukai T; Ogura T; Makino H
Am J Physiol Renal Physiol; 2007 May; 292(5):F1513-25. PubMed ID: 17244894
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease.
Bertocchio JP; Warnock DG; Jaisser F
Kidney Int; 2011 May; 79(10):1051-60. PubMed ID: 21412221
[TBL] [Abstract][Full Text] [Related]
15. [Aldosterone and kidney diseases: an emergent paradigm with important clinical implications].
Bertocchio JP; Jaisser F
Nephrol Ther; 2011 Jun; 7(3):139-47. PubMed ID: 21144811
[TBL] [Abstract][Full Text] [Related]
16. Aldosterone induces superoxide generation via Rac1 activation in endothelial cells.
Iwashima F; Yoshimoto T; Minami I; Sakurada M; Hirono Y; Hirata Y
Endocrinology; 2008 Mar; 149(3):1009-14. PubMed ID: 18079208
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone and glomerular podocyte injury.
Nagase M; Fujita T
Clin Exp Nephrol; 2008 Aug; 12(4):233-242. PubMed ID: 18317876
[TBL] [Abstract][Full Text] [Related]
18. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors.
Nagase M; Yoshida S; Shibata S; Nagase T; Gotoda T; Ando K; Fujita T
J Am Soc Nephrol; 2006 Dec; 17(12):3438-46. PubMed ID: 17082236
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation.
Huang S; Zhang A; Ding G; Chen R
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1323-33. PubMed ID: 19339632
[TBL] [Abstract][Full Text] [Related]
20. Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury.
Sun GP; Kohno M; Guo P; Nagai Y; Miyata K; Fan YY; Kimura S; Kiyomoto H; Ohmori K; Li DT; Abe Y; Nishiyama A
J Am Soc Nephrol; 2006 Aug; 17(8):2193-201. PubMed ID: 16790507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
